{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:03:09Z","timestamp":1772150589380,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.avsg.2025.10.010","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T23:28:29Z","timestamp":1760570909000},"page":"444-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A Review on the Disease Risk and Contemporary Management of Peripheral Arterial Disease in the HIV Population"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8746-207X","authenticated-orcid":false,"given":"Michael C.","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy O.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon C.","family":"Kiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2025.10.010_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1185\/030079908X253654","article-title":"C-reactive protein (CRP): more than just an innocent bystander?","volume":"24","author":"Paraskevas","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.avsg.2025.10.010_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2008.02.026","article-title":"Do we need to consider inflammatory markers when we treat atherosclerotic disease?","volume":"200","author":"Athyros","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.avsg.2025.10.010_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/QAI.0000000000001795","article-title":"Brief report: prevalence of peripheral artery disease is higher in persons living with HIV compared with uninfected controls","volume":"79","author":"Knudsen","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.avsg.2025.10.010_bib4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.CIR.100.7.700","article-title":"Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV cohort study","volume":"100","author":"Periard","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2025.10.010_bib5","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2025.10.010_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11904-016-0331-y","article-title":"Atherosclerotic cardiovascular disease and anti-retroviral therapy","volume":"13","author":"Kaplan-Lewis","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.avsg.2025.10.010_bib7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/527564","article-title":"High prevalence of peripheral arterial disease in HIV-infected persons","volume":"46","author":"Periard","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.avsg.2025.10.010_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/15347346211009404","article-title":"The prevalence and risk factors for peripheral arterial disease in adults living with human immunodeficiency virus","volume":"22","author":"Rerkasem","year":"2023","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.avsg.2025.10.010_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/jamasurg.2014.2257","article-title":"Thirty-day postoperative mortality among individuals with HIV infection receiving antiretroviral therapy and procedure-matched, uninfected comparators","volume":"150","author":"King","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.avsg.2025.10.010_bib10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejvs.2007.06.007","article-title":"Surgical intervention for HIV related vascular disease","volume":"34","author":"Botes","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"Suppl 1","key":"10.1016\/j.avsg.2025.10.010_bib11","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.ejvs.2009.12.028","article-title":"Management of HIV vasculopathy - a South African experience","volume":"39","author":"Robbs","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2025.10.010_bib12","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jvs.2021.09.034","article-title":"Symptomatic human immunodeficiency virus infection is associated with advanced presentation and perioperative mortality in patients undergoing surgery for peripheral arterial disease","volume":"75","author":"Tran","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2025.10.010_bib13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/1358863X231191822","article-title":"Longitudinal outcomes following peripheral vascular intervention among older persons living with HIV","volume":"28","author":"Kentoffio","year":"2023","journal-title":"Vasc Med"},{"key":"10.1016\/j.avsg.2025.10.010_bib14","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0000000000003309","article-title":"Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population","volume":"36","author":"Teng","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.avsg.2025.10.010_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/1358863X20952856","article-title":"Trends and perioperative outcomes of patients with human immunodeficiency virus (HIV) undergoing lower extremity revascularization","volume":"25","author":"Kim","year":"2020","journal-title":"Vasc Med"},{"key":"10.1016\/j.avsg.2025.10.010_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCULATIONAHA.117.032647","article-title":"Association of human immunodeficiency virus infection and risk of peripheral artery disease","volume":"138","author":"Beckman","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2025.10.010_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejvs.2016.06.007","article-title":"Endovascular therapy for large vessel vasculopathy in HIV-infected patients","volume":"52","author":"Pillay","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2025.10.010_bib18","first-page":"36","article-title":"HIV-occlusive vascular disease","volume":"47","author":"van Marle","year":"2009","journal-title":"S Afr J Surg"},{"key":"10.1016\/j.avsg.2025.10.010_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1078-5884(00)91195-X","article-title":"Occlusive arterial disease in HIV-infected patients: a preliminary report","volume":"20","author":"Nair","year":"2000","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2025.10.010_bib20","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2025.10.010_bib21","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2025.10.010_bib22","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/aid.2008.0001","article-title":"Peripheral arterial disease in HIV patients older than 50 years of age","volume":"24","author":"Palacios","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.avsg.2025.10.010_bib23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/QAI.0b013e318157b0b3","article-title":"Low prevalence of peripheral arterial disease in HIV-Infected patients with multiple cardiovascular risk factors","volume":"47","author":"Bernal","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.avsg.2025.10.010_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1293.2008.00638.x","article-title":"Ankle-branch index and HIV: the role of antiretrovirals","volume":"10","author":"Olalla","year":"2009","journal-title":"HIV Med"},{"issue":"Suppl 1","key":"10.1016\/j.avsg.2025.10.010_bib25","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2025.10.010_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/M17-1058","article-title":"Readmissions after revascularization procedures for peripheral arterial disease: a nationwide cohort study","volume":"168","author":"Secemsky","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.avsg.2025.10.010_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012241","article-title":"HIV infection and incidence of cardiovascular diseases: an analysis of a large healthcare database","volume":"8","author":"Alonso","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2025.10.010_bib28","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1016\/j.ahj.2003.10.018","article-title":"Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors","volume":"147","author":"Stein","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.avsg.2025.10.010_bib29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/QAI.0b013e31828a292c","article-title":"Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study","volume":"63","author":"O'Brien","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.avsg.2025.10.010_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/QAI.0000000000000954","article-title":"Do biomarkers of inflammation, monocyte activation, and altered coagulation explain excess mortality between HIV infected and uninfected people?","volume":"72","author":"So-Armah","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.avsg.2025.10.010_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.tcm.2021.02.006","article-title":"Coronary revascularization in patients with HIV","volume":"32","author":"McCutcheon","year":"2022","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.avsg.2025.10.010_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fcvm.2018.00185","article-title":"HIV proteins and endothelial dysfunction: implications in cardiovascular disease","volume":"5","author":"Anand","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.avsg.2025.10.010_bib33","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/febs.14657","article-title":"Vascular endothelial dysfunction in the wake of HIV and ART","volume":"286","author":"Marincowitz","year":"2019","journal-title":"FEBS J"},{"key":"10.1016\/j.avsg.2025.10.010_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/S1413-86702006000200012","article-title":"Endothelial function and cardiovascular diseases in HIV infected patient","volume":"10","author":"Andrade","year":"2006","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.avsg.2025.10.010_bib35","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1086\/521935","article-title":"Ten-year predicted coronary heart disease risk in HIV-infected men and women","volume":"45","author":"Kaplan","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.avsg.2025.10.010_bib36","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1017\/gheg.2018.7","article-title":"HIV treatment is associated with a two-fold higher probability of raised triglycerides: pooled analyses in 21,023 individuals in Sub-Saharan Africa","volume":"3","author":"Ekoru","year":"2018","journal-title":"Glob Health Epidemiol Genom"},{"key":"10.1016\/j.avsg.2025.10.010_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201404","article-title":"The association between antiretroviral therapy and selected cardiovascular disease risk factors in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"13","author":"Dimala","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.avsg.2025.10.010_bib38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"201","author":"Worm","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.avsg.2025.10.010_bib39","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(09)62041-9","article-title":"Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials","volume":"375","author":"Eron","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2025.10.010_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013744","article-title":"Excess risk for atherosclerotic cardiovascular outcomes among US adults with HIV in the current era","volume":"9","author":"Rosenson","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2025.10.010_bib41","author":"Kemnic"},{"key":"10.1016\/j.avsg.2025.10.010_bib42","first-page":"1073","article-title":"Prevention. HIV prevalence estimates--United states, 2006","volume":"57","author":"Centers for Disease","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.avsg.2025.10.010_bib43","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1093\/ndt\/gfq125","article-title":"Kidney transplants in HIV-positive recipients under HAART. A comprehensive review and meta-analysis of 12 series","volume":"25","author":"Landin","year":"2010","journal-title":"Nephrol Dial Transpl"},{"issue":"Suppl 4","key":"10.1016\/j.avsg.2025.10.010_bib44","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1111\/j.1600-6143.2009.02903.x","article-title":"Solid organ transplantation in the HIV-infected patient","volume":"9","author":"Blumberg","year":"2009","journal-title":"Am J Transpl"},{"issue":"Suppl 21","key":"10.1016\/j.avsg.2025.10.010_bib45","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1399-0012.2009.01112.x","article-title":"Liver transplantation in HIV-positive patients","volume":"23","author":"Eisenbach","year":"2009","journal-title":"Clin Transpl"},{"key":"10.1016\/j.avsg.2025.10.010_bib46","first-page":"320","article-title":"Cardiac surgery in HIV patients: state of the art","volume":"35","author":"Yanagawa","year":"2019","journal-title":"Can J Cardiol"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509625006843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509625006843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:41:25Z","timestamp":1772149285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509625006843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":46,"alternative-id":["S0890509625006843"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2025.10.010","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Review on the Disease Risk and Contemporary Management of Peripheral Arterial Disease in the HIV Population","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2025.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}